HNGE Form 144: Sale of 373,955 Shares Worth $15.27M Disclosed

HNGE shareholder filed a Rule 144 notice to sell 373,955 Class A shares, with an aggregate market value of 15,272,322.2.

Accepted by SEC EDGAR 11/18/2025 - 04:55 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

HNGE shareholder filed a Rule 144 notice to sell 373,955 Class A shares, with an aggregate market value of 15,272,322.2. These shares were originally acquired from the issuer in a private placement on 02/04/2020 and paid for in cash. The proposed sales are expected to begin around 11/18/2025 through broker Merrill Lynch on the NYSE. The notice states that 37,919,155 Class A shares are outstanding, giving context for the size of this planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HNGE's Form 144 filing disclose?

The filing discloses that a shareholder of HNGE plans to sell 373,955 Class A shares under Rule 144, providing details on the shares, their origin, and the planned sale method.

How many HNGE shares are proposed for sale in this Form 144?

The notice covers a proposed sale of 373,955 Class A shares, with an aggregate market value of 15,272,322.2.

When were the HNGE shares acquired and how were they paid for?

The 373,955 Class A shares were acquired on 02/04/2020 in a private placement from the issuer and were paid for in cash.

When does the Form 144 indicate the HNGE shares may be sold?

The approximate date of sale listed is 11/18/2025, indicating when the shareholder expects to begin selling the shares.

On which exchange and through which broker will the HNGE shares be sold?

The planned sales are to be executed on the NYSE through broker Merrill Lynch, located at One Bryant Park, New York, NY 10036.

How many HNGE Class A shares are outstanding according to the Form 144?

The notice states that there are 37,919,155 Class A shares outstanding, which provides scale relative to the 373,955 shares covered by this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001768640
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET, 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Bessemer Venture Partners X LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Merrill Lynch One Bryant Park New York NY 10036	373955	15272322.2	37919155	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	02/04/2020	Private Placement	Issuer			373955	02/04/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Augie Wilkinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)